NCT00873483View on ClinicalTrials.gov

US Ovulation Inhibition Study in Obese Women

PHASE2CompletedINTERVENTIONAL

Enrollment

173

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

March 3, 2010

Study Completion Date

March 3, 2010

Conditions

Contraception

Interventions

DRUG

Ethinylestradiol/Gestodene (BAY86-5016)

0.55 mg ethinyl estradiol \& 2.1 mg gestodene, 21 days for 3 cycles

Trial Locations (6)

19114

Philadelphia

30328

Sandy Springs

77054

Houston

85712

Tucson

92108

San Diego

98105

Seattle

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY